Medico Remedies Limited (MEDICO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Medico Remedies Limited (MEDICO) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs6.43 Million ≈ $69.54K USD) by net assets (Rs668.58 Million ≈ $7.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medico Remedies Limited (MEDICO) total market value for the company's overall valuation and market capitalisation.

Medico Remedies Limited - Cash Flow Conversion Efficiency Trend (2013–2026)

This chart illustrates how Medico Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medico Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medico Remedies Limited ranked by their cash flow conversion efficiency. Explore Medico Remedies Limited earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Aarey Drugs & Pharmaceuticals Limited
NSE:AAREYDRUGS
0.006x
Maquia Capital Acquisition Corp
NASDAQ:MAQC
0.008x
Century Lithium Corp.
V:LCE
-0.005x
NPD Co. Ltd
KQ:198080
0.037x
ORTOMA AB B
F:82Y
-0.120x
Jeil Steel Mfg Co. Ltd
KQ:023440
-0.047x
Dusk Group Ltd
AU:DSK
-0.078x
TDb Split Corp
TO:XTD
-0.045x

Annual Cash Flow Conversion Efficiency for Medico Remedies Limited (2013–2026)

The table below shows the annual cash flow conversion efficiency of Medico Remedies Limited from 2013 to 2026. View MEDICO live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs754.74 Million
≈ $8.16 Million
Rs10.06 Million
≈ $108.82K
0.013x -82.98%
2025-03-31 Rs624.69 Million
≈ $6.76 Million
Rs48.92 Million
≈ $529.06K
0.078x +68.23%
2024-03-31 Rs523.71 Million
≈ $5.66 Million
Rs24.38 Million
≈ $263.65K
0.047x -75.01%
2023-03-31 Rs438.43 Million
≈ $4.74 Million
Rs81.67 Million
≈ $883.25K
0.186x +18.60%
2022-03-31 Rs373.20 Million
≈ $4.04 Million
Rs58.62 Million
≈ $633.95K
0.157x +145.08%
2021-03-31 Rs324.58 Million
≈ $3.51 Million
Rs-113.10 Million
≈ $-1.22 Million
-0.348x -1175.78%
2020-03-31 Rs298.66 Million
≈ $3.23 Million
Rs9.67 Million
≈ $104.62K
0.032x -81.43%
2019-03-31 Rs282.36 Million
≈ $3.05 Million
Rs49.24 Million
≈ $532.54K
0.174x -8.75%
2018-03-31 Rs266.66 Million
≈ $2.88 Million
Rs50.97 Million
≈ $551.17K
0.191x +202.51%
2017-03-31 Rs163.72 Million
≈ $1.77 Million
Rs-30.52 Million
≈ $-330.12K
-0.186x +26.28%
2016-03-31 Rs147.44 Million
≈ $1.59 Million
Rs-37.29 Million
≈ $-403.27K
-0.253x -980.71%
2015-03-31 Rs136.14 Million
≈ $1.47 Million
Rs-3.19 Million
≈ $-34.46K
-0.023x -107.36%
2014-03-31 Rs85.72 Million
≈ $927.00K
Rs27.27 Million
≈ $294.96K
0.318x -21.78%
2013-03-31 Rs50.55 Million
≈ $546.71K
Rs20.57 Million
≈ $222.40K
0.407x --

About Medico Remedies Limited

NSE:MEDICO India Drug Manufacturers - Specialty & Generic
Market Cap
$31.31 Million
Rs2.90 Billion INR
Market Cap Rank
#23717 Global
#1309 in India
Share Price
Rs34.89
Change (1 day)
-3.99%
52-Week Range
Rs32.76 - Rs54.24
All Time High
Rs96.70
About

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more